MiMedx Group, Inc

(NASDAQ:MDXG)

Latest On MiMedx Group, Inc (MDXG):

Date/Time Type Description Signal Details
2023-05-06 11:18 ESTNewsMiMedx's Post-Q1 2023 Surge Could Result In Profit-TakingN/A
2023-05-03 19:46 ESTNewsMiMedx surges ~30% after Q1 revenue growth, cost controls drive down net lossN/A
2023-05-03 06:37 ESTNewsMiMedx Group, Inc. (MDXG) Q1 2023 Earnings Call TranscriptN/A
2023-05-02 18:35 ESTNewsMiMedx Group GAAP EPS of -$0.06 beats by $0.03, revenue of $71.68M beats by $7.53MN/A
2023-05-01 18:02 ESTNewsMiMedx Group Q1 2023 Earnings PreviewN/A
2023-03-24 05:26 ESTNewsMiMedx CFO Carlson to leave companyN/A
2023-03-01 05:59 ESTNewsMiMedx Group GAAP EPS of -$0.02, revenue of $74.38MN/A
2023-03-01 05:59 ESTNewsMiMedx Group, Inc. (MDXG) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 00:24 ESTNewsMiMedx Group Q4 2022 Earnings PreviewN/A
2023-01-30 10:01 ESTNewsMiMedx appoints deal maker Joseph Capper as new CEON/A
2023-01-10 18:33 ESTNewsMIMEDX continues to see Q4 net sales in the range of $73M to $76MN/A
2023-01-09 12:05 ESTNewsMIMEDX continues to see Q4 net sales in the ranges of $73M to $76MN/A
2023-01-05 04:25 ESTNewsMiMedx announces commercial launch of EPIFIX product in Japan with distribution dealN/A
2022-11-03 04:07 ESTNewsMiMedx Group GAAP EPS of -$0.09 in-line, revenue of $67.69M beats by $0.96MN/A
2022-11-03 04:07 ESTNewsMiMedx Group, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-03 04:07 ESTNewsMiMedx Group, Inc. (MDXG) Q3 2022 Earnings Call TranscriptN/A
2022-11-01 20:49 ESTNewsMiMedx Group Q3 2022 Earnings PreviewN/A
2022-09-13 05:10 ESTNewsMiMedx gets Japanese reimbursement approval for its tissue allograft EPIFIXN/A
2022-09-06 20:37 ESTNewsMiMedx Group expects AWC full-year sales in low end of 11%-14% growth rangeN/A
2022-08-03 15:56 ESTNewsMiMedx Group, Inc.'s (MDXG) CEO Tim Wright on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-03 01:47 ESTNewsMiMedx Group GAAP EPS of -$0.11 misses by $0.04, revenue of $66.88M beats by $1.81MN/A
2022-08-01 20:44 ESTNewsMiMedx Group Q2 2022 Earnings PreviewN/A
2022-06-15 20:40 ESTNewsMiMedx contracts with Nordic Bioscience to support knee osteoarthritis therapy trialsN/A
2022-05-31 16:59 ESTNewsMiMedx wins $4.6M contract from US DoD for wound, burn care solutionN/A
2022-05-04 19:58 ESTNewsMiMedx Group, Inc. (MDXG) CEO Tim Wright on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 02:02 ESTNewsMiMedx Group GAAP EPS of -$0.11 misses by $0.01, revenue of $58.89M beats by $4.79MN/A
2022-05-03 07:47 ESTNewsMiMedx Group Q1 2022 Earnings PreviewN/A
2022-03-28 10:49 ESTNewsMiMedx Group (MDXG) Presents at the Canaccord Genuity Musculoskeletal Conference - SlideshowN/A
2022-03-01 01:21 ESTNewsMiMedx Group GAAP EPS of $0.01 beats by $0.04, revenue of $67.29M beats by $3.6MN/A
2022-03-01 01:21 ESTNewsMiMedx Group, Inc. (MDXG) CEO Tim Wright on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 05:34 ESTNewsMiMedx Group Q4 2021 Earnings PreviewN/A
2022-01-28 18:51 ESTNewsMiMedx rises as federal court dismisses securities class action lawsuit against companyN/A
2022-01-11 06:38 ESTNewsMiMedx sees 2022 annual revenue growth of 11%-14%, outlines key strategic milestones for 2022N/A
2021-12-08 00:17 ESTNewsMiMedx raises sales guidance ahead of investor eventN/A
2021-11-04 01:45 ESTNewsMiMedx up 15% as net loss narrows in Q3 and beats Street expectationsN/A
2021-11-04 01:45 ESTNewsMiMedx Group, Inc. (MDXG) CEO Tim Wright on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-03 05:58 ESTNewsMiMedx Group EPS beats by $0.05, beats on revenueN/A
2021-11-02 10:13 ESTNewsMiMedx Group Q3 2021 Earnings PreviewN/A
2021-10-12 18:41 ESTNewsWarning: MDXG is at high risk of performing badlyN/A
2021-10-07 01:59 ESTNewsMDXG is at high risk of performing badlyN/A
2021-09-27 10:20 ESTNewsWarning: MDXG has been downgraded to Very BearishN/A
2021-09-25 16:06 ESTNewsBELLUS Health, Akoya Biosciences lead weekly healthcare gainers; Protagonist trailN/A
2021-09-22 17:52 ESTNewsMiMedx plunges after setback for two late-stage musculoskeletal clinical trialsN/A
2021-09-22 17:50 ESTNewsWarning: MDXG has been downgraded to Very Bearish.N/A
2021-09-22 17:50 ESTNewsBELLUS Health, Akoya Biosciences lead weakly healthcare gainers; Protagonist trailN/A
2021-08-27 22:13 ESTNewsMiMedx Group files registration statement on Form S-3N/A
2021-08-04 21:40 ESTNewsMiMedx Group, Inc. (MDXG) CEO Tim Wright on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-04 00:54 ESTNewsMiMedx Group EPS beats by $0.04, beats on revenueN/A
2021-07-22 16:23 ESTNewsMimedx's Epifix secures regulatory approval in JapanN/A
2021-07-22 16:19 ESTNewsMiMedx joins Russell 3000 and 2000 IndexesN/A

About MiMedx Group, Inc (MDXG):

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and burns; AmnioFix, a semi-permeable protective barrier membrane product for the treatment of wounds related to surgical procedures; EpiCord and AmnioCord that are dehydrated human umbilical cord allografts intended for homologous applications; and AmnioFill that consists of particles of connective tissue matrix derived from placental disc and placental membranes. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.

MDXG Quotes by TradingView

See Advanced Chart

General

  • Name MiMedx Group, Inc
  • Symbol MDXG
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Devices
  • Full Time Employees 735
  • Last Split Factor3235:10000
  • Last Split Date2008-04-02
  • Fiscal Year EndDecember
  • IPO Date2007-08-22
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.mimedx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 3.94
  • Price/Book (Most Recent Quarter) 85.59
  • Enterprise Value Revenue 3.86
  • Enterprise Value EBITDA 117.93
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.05
  • Next Year EPS Estimate $0.22
  • Profit Margin -20%
  • Operating Margin -18%
  • Return on Assets -15%
  • Return on Equity -78%
  • Revenue 248.23 million
  • Earnings Per Share $0.31
  • Revenue Per Share $2.29
  • Gross Profit 208.9 million
  • Quarterly Earnings Growth -10.3%
View More

Highlights

  • Market Capitalization 980.21 million
  • EBITDA 7.71 million
  • PE Ratio 10.9
  • PEG Ratio 2.97
  • Analyst Target Price $16
  • Book Value Per Share $0.12
View More

Share Statistics

  • Shares Outstanding 111.04 million
  • Shares Float 74.07 million
  • % Held by Insiders 637%
  • % Held by Institutions 12.1%
  • Shares Short 7.57 million
  • Shares Short Prior Month 7.54 million
  • Short Ratio 15.29
  • Short % of Float 9%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 1.66
  • 52 Week High $11.44
  • 52 Week Low $2.95
  • 50 Day Moving Average 9.84
  • 200 Day Moving Average 7.82
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

MiMedx Group, Inc (MDXG) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

MiMedx Group, Inc (MDXG) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-08$68.55 million-$0.17-$0.05-240%
2020-09-302020-11-04$N/A-$0.48
2020-06-302020-07-06$53.65 million-$0.04
2020-03-312020-06-30$61.74 million-$0.08$0.00
2019-12-312020-03-31$76.4 million-$0.04$0.11-140.73%
2019-09-302019-12-31$88.86 million-$0.07
2019-06-302019-09-30$67.44 million$0.11
2019-03-312019-06-30$66.56 million-$0.16
2018-12-312019-03-31$N/A-$0.12$0.00
2018-09-302018-12-31-$0.33$0.00
2018-06-302018-07-26$0.02
2018-03-312018-04-26$0.04
2017-12-312017-12-31$0.38$0.11245.45%
2017-09-302017-10-26$84.57 million$0.15$0.05200%
2017-06-302017-07-26$76.41 million$0.07$0.0483.25%
2017-03-312017-04-28$72.61 million$0.04$0.045.26%
2016-12-312017-02-23$69.88 million$0.05$0.0427.55%
2016-09-302016-10-27$64.43 million$0.03$0.0242.18%
2016-06-302016-07-26$57.34 million$0.02$0.03-30.31%
2016-03-312016-04-26$53.37 million$0.01$0.04-76.19%
2015-12-312016-02-23$51.84 million$0.12$0.06100%
2015-09-302015-10-29$49.02 million$0.06$0.060%
2015-06-302015-07-30$45.68 million$0.05$0.050%
2015-03-312015-04-27$40.77 million$0.04$0.0333.33%
2014-12-312015-02-26$39.57 million$0.03$0.030%
2014-09-302014-10-30$33.52 million$0.03$0.0250%
2014-06-302014-07-28$25.57 million$-0.00
2014-03-312014-04-25$19.56 million-$0.01-$0.0250%
2013-12-312014-02-26$17.99 million-$0.01-$0.010%
2013-09-302013-10-30$16.12 million$-0.00
2013-06-302013-07-31$13.52 million-$0.01-$0.010%
2013-03-312013-05-01$11.56 million-$0.02-$0.01-100%
2012-12-312013-03-07$10.51 million-$0.02-$0.01-100%
2012-09-302012-11-28$7.95 million-$0.05
2012-06-302012-08-29$4.88 million-$0.01
2012-03-312012-05-30$3.71 million-$0.01
2011-12-312011-12-31$2.64 million-$0.04
2011-09-302011-09-30$2.15 million-$0.02
2011-06-302011-06-30$1.93 million-$0.03
2011-03-312011-03-31$1.04 million-$0.05
2010-12-312010-12-31-$0.05
2010-09-302010-09-30-$0.05
2010-06-302010-06-30-$0.04
2010-03-312010-03-31-$0.06
2008-12-312008-12-31-$0.08
2008-09-302008-09-30-$0.13
2008-06-302008-06-30-$0.09

MiMedx Group, Inc (MDXG) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

MiMedx Group, Inc (MDXG) Chart:

MDXG chart by TradingView

MiMedx Group, Inc (MDXG) News:

Below you will find a list of latest news for MiMedx Group, Inc (MDXG) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

MiMedx Group, Inc (MDXG) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-172.54.66CALL1 0858.83TRUE4.660
2025-04-1750CALL0 0239.25TRUE00
2025-04-177.50.3CALL419 1401170.32FALSE0.30
2025-04-17100CALL0 0258.67FALSE00
2025-04-1712.50CALL0 0750.15FALSE00
2025-04-17150CALL0 0842.1FALSE00
2025-04-172.50PUT0 00FALSE00
2025-04-1750.15PUT13 0267.14FALSE0.150
2025-04-177.51PUT0 817176.64TRUE00
2025-04-17100PUT0 0425.49TRUE00
2025-04-1712.50PUT0 0492.26TRUE00
2025-04-17150PUT0 0695.12TRUE00
2025-05-162.50CALL0 0341.91TRUE00
2025-05-1650CALL0 0173.97TRUE00
2025-05-167.50CALL0 070.68FALSE00
2025-05-16100CALL0 0149.13FALSE00
2025-05-1612.50CALL0 0286.97FALSE00
2025-05-16150CALL0 0398.56FALSE00
2025-05-162.50PUT0 0604.3FALSE00
2025-05-1650PUT0 0157.98FALSE00
2025-05-167.50PUT0 0100.44TRUE00
2025-05-16100PUT0 073.47TRUE00
2025-05-1612.50PUT0 0222.7TRUE00
2025-05-16150PUT0 0249.87TRUE00
2025-06-202.55.98CALL0 0287.28TRUE00
2025-06-2051.22CALL0 163.03TRUE00
2025-06-207.50.98CALL0 136137.98FALSE00
2025-06-20100.15CALL0 15264.66FALSE00
2025-06-2012.50.1CALL0 6578.13FALSE00
2025-06-20150CALL0 0225.68FALSE00
2025-06-2017.50CALL0 0245.29FALSE00
2025-06-202.50PUT0 0608.17FALSE00
2025-06-2050.25PUT0 20977.12FALSE00
2025-06-207.50.6PUT0 37563.39TRUE00
2025-06-20101PUT0 1148.47TRUE00
2025-06-2012.50PUT0 0226.29TRUE00
2025-06-20150PUT0 0184.38TRUE00
2025-06-2017.50PUT0 0204.34TRUE00
2025-09-192.50CALL0 0248.46TRUE00
2025-09-1953.13CALL0 145.35TRUE00
2025-09-197.50.73CALL1 3051.9FALSE-0.07-0.09
2025-09-19100.3CALL0 4156.89FALSE00
2025-09-1912.50.15CALL0 294.51FALSE00
2025-09-19150CALL0 0147.3FALSE00
2025-09-192.50PUT0 0281.87FALSE00
2025-09-1950PUT0 078.81FALSE00
2025-09-197.50.95PUT0 17659.2TRUE00
2025-09-19103.15PUT0 5255.99TRUE00
2025-09-1912.50PUT0 096.29TRUE00
2025-09-19150PUT0 0123.48TRUE00

Latest MDXG Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST300$3.175
Jun 13, 2022 7:59 PM EST100$3.175
Jun 13, 2022 7:59 PM EST100$3.175
Jun 13, 2022 7:59 PM EST400$3.175
Jun 13, 2022 7:59 PM EST2$3.17

MiMedx Group, Inc (MDXG) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000035/0001376339-20-000035-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000089924320019006/0000899243-20-019006-index.htm
2019-06-14DFAN14AAdditional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1376339/000090266419002778/0000902664-19-002778-index.htm
2019-06-17DFAN14AAdditional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1376339/000090266419002784/0000902664-19-002784-index.htm
2019-06-17DFAN14AAdditional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1376339/000090266419002785/0000902664-19-002785-index.htm
2020-07-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1376339/000101143820000168/0001011438-20-000168-index.htm
2020-07-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1376339/000101143820000171/0001011438-20-000171-index.htm
2020-07-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000101783220000002/0001017832-20-000002-index.htm
2020-08-283/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000101783220000004/0001017832-20-000004-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1376339/000101905620000163/0001019056-20-000163-index.htm
2019-06-13DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1376339/000119312519172511/0001193125-19-172511-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000119312519173104/0001193125-19-173104-index.htm
2019-06-14DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1376339/000119312519173699/0001193125-19-173699-index.htm
2019-06-14DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1376339/000119312519173708/0001193125-19-173708-index.htm
2019-06-14DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1376339/000119312519173715/0001193125-19-173715-index.htm
2019-06-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1376339/000119312519174775/0001193125-19-174775-index.htm
2019-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000119312519176584/0001193125-19-176584-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000119312519213015/0001193125-19-213015-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000119312519217216/0001193125-19-217216-index.htm
2019-08-09NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1376339/000119312519218035/0001193125-19-218035-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000119312520187301/0001193125-20-187301-index.htm
2020-07-13SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1376339/000119312520191931/0001193125-20-191931-index.htm
2020-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000119312520193404/0001193125-20-193404-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000119312520214251/0001193125-20-214251-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000119312520235594/0001193125-20-235594-index.htm
2020-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000119312520248152/0001193125-20-248152-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000119312520249566/0001193125-20-249566-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000119312520250221/0001193125-20-250221-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000128824520000002/0001288245-20-000002-index.htm
2020-11-03CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1376339/000135445720000665/0001354457-20-000665-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000025/0001376339-19-000025-index.htm
2019-06-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000027/0001376339-19-000027-index.htm
2019-06-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000028/0001376339-19-000028-index.htm
2019-06-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000029/0001376339-19-000029-index.htm
2019-06-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000030/0001376339-19-000030-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000032/0001376339-19-000032-index.htm
2019-08-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000034/0001376339-19-000034-index.htm
2019-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000036/0001376339-19-000036-index.htm
2019-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000038/0001376339-19-000038-index.htm
2019-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000039/0001376339-19-000039-index.htm
2019-11-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000041/0001376339-19-000041-index.htm
2019-11-12NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000043/0001376339-19-000043-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000048/0001376339-19-000048-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633919000050/0001376339-19-000050-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000002/0001376339-20-000002-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000004/0001376339-20-000004-index.htm
2020-03-1710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1376339/000137633920000009/0001376339-20-000009-index.htm
2020-03-18NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1376339/000137633920000010/0001376339-20-000010-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000011/0001376339-20-000011-index.htm
2020-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000013/0001376339-20-000013-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000015/0001376339-20-000015-index.htm
2020-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000017/0001376339-20-000017-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000019/0001376339-20-000019-index.htm
2020-04-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000023/0001376339-20-000023-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000024/0001376339-20-000024-index.htm
2020-04-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000025/0001376339-20-000025-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000027/0001376339-20-000027-index.htm
2020-05-11NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000030/0001376339-20-000030-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000031/0001376339-20-000031-index.htm
2020-05-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000033/0001376339-20-000033-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000035/0001376339-20-000035-index.htm
2020-07-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1376339/000137633920000045/0001376339-20-000045-index.htm
2020-07-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1376339/000137633920000047/0001376339-20-000047-index.htm
2020-07-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1376339/000137633920000051/0001376339-20-000051-index.htm
2020-07-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1376339/000137633920000052/0001376339-20-000052-index.htm
2020-07-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1376339/000137633920000053/0001376339-20-000053-index.htm
2020-07-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000055/0001376339-20-000055-index.htm
2020-07-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000058/0001376339-20-000058-index.htm
2020-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000060/0001376339-20-000060-index.htm
2020-07-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000062/0001376339-20-000062-index.htm
2020-08-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000066/0001376339-20-000066-index.htm
2020-08-03DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000067/0001376339-20-000067-index.htm
2020-08-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000069/0001376339-20-000069-index.htm
2020-08-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1376339/000137633920000072/0001376339-20-000072-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000073/0001376339-20-000073-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000084/0001376339-20-000084-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000085/0001376339-20-000085-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000086/0001376339-20-000086-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000087/0001376339-20-000087-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000088/0001376339-20-000088-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000089/0001376339-20-000089-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000090/0001376339-20-000090-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000091/0001376339-20-000091-index.htm
2020-08-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000093/0001376339-20-000093-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000095/0001376339-20-000095-index.htm
2020-08-283/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000097/0001376339-20-000097-index.htm
2020-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000099/0001376339-20-000099-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000105/0001376339-20-000105-index.htm
2020-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000107/0001376339-20-000107-index.htm
2020-10-058-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000112/0001376339-20-000112-index.htm
2020-10-05PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000122/0001376339-20-000122-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000123/0001376339-20-000123-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000124/0001376339-20-000124-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000125/0001376339-20-000125-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000126/0001376339-20-000126-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000127/0001376339-20-000127-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000128/0001376339-20-000128-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000129/0001376339-20-000129-index.htm
2020-10-15DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000132/0001376339-20-000132-index.htm
2020-10-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000134/0001376339-20-000134-index.htm
2020-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000137/0001376339-20-000137-index.htm
2020-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000139/0001376339-20-000139-index.htm
2020-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000142/0001376339-20-000142-index.htm
2020-11-028-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1376339/000137633920000144/0001376339-20-000144-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1376339/000137633920000147/0001376339-20-000147-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1376339/000137633920000148/0001376339-20-000148-index.htm
2019-12-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137932019000004/0001379320-19-000004-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137932019000006/0001379320-19-000006-index.htm
2020-07-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137932020000002/0001379320-20-000002-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137932020000004/0001379320-20-000004-index.htm
2020-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000137932020000006/0001379320-20-000006-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000143565520000002/0001435655-20-000002-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000176179620000002/0001761796-20-000002-index.htm
2019-12-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000179604419000002/0001796044-19-000002-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000179604420000002/0001796044-20-000002-index.htm
2020-02-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000180389320000002/0001803893-20-000002-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000180389320000004/0001803893-20-000004-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000181181420000002/0001811814-20-000002-index.htm
2020-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1376339/000181181420000004/0001811814-20-000004-index.htm

MiMedx Group, Inc (MDXG) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of MiMedx Group, Inc (MDXG). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 637%
Institutional Ownership: 1210%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-05NEIL YESTONDirectorBuy29,661.00100,121.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000084/0001376339-20-000084-index.htm
2020-08-05TIMOTHY R WRIGHTChief Executive OfficerBuy572,033.001,164,260.00https://www.sec.gov/Archives/edgar/data/1376339/000128824520000002/0001288245-20-000002-index.htm
2020-08-05William Frank IV HulseGeneral CounselBuy120,762.00120,762.00https://www.sec.gov/Archives/edgar/data/1376339/000179604420000002/0001796044-20-000002-index.htm
2020-10-02Charles Robert EvansDirectorBuy26,236.006.67174,994.12121,357.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000125/0001376339-20-000125-index.htm
2020-10-02NEIL YESTONDirectorBuy26,236.006.67174,994.12126,357.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000129/0001376339-20-000129-index.htm
2020-10-02CHARLES E KOOBDirectorBuy26,236.006.67174,994.121,431,525.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000127/0001376339-20-000127-index.htm
2020-01-22CHARLES E KOOBDirectorBuy15,000.001.2018,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000002/0001376339-20-000002-index.htm
2020-08-05CHARLES E KOOBDirectorBuy29,661.001,505,289.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000089/0001376339-20-000089-index.htm
2020-08-05Scott M TurnerSVP, Operations & ProcurementBuy48,135.00152,978.00https://www.sec.gov/Archives/edgar/data/1376339/000176179620000002/0001761796-20-000002-index.htm
2020-08-05J TERRY DEWBERRYDirectorBuy29,661.00156,787.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000091/0001376339-20-000091-index.htm
2020-08-03Rohit KashyapEVP & Chief Commercial OfficerBuy173,310.005.77999,998.70173,310.00https://www.sec.gov/Archives/edgar/data/1376339/000143565520000002/0001435655-20-000002-index.htm
2019-06-20JOSEPH G BLESERDirectorBuy50,000.000.7035,000.00181,545.00https://www.sec.gov/Archives/edgar/data/1376339/000137633919000025/0001376339-19-000025-index.htm
2020-08-05Peter M CarlsonChief Financial OfficerBuy177,966.00262,472.00https://www.sec.gov/Archives/edgar/data/1376339/000137932020000004/0001379320-20-000004-index.htm
2020-11-04Peter M CarlsonChief Financial OfficerBuy35,211.007.23254,575.53297,683.00https://www.sec.gov/Archives/edgar/data/1376339/000137932020000006/0001379320-20-000006-index.htm
2020-08-05Richard BarryDirectorBuy38,135.003,338,135.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000088/0001376339-20-000088-index.htm
2020-08-05JAMES L BIERMANDirectorBuy38,135.0038,135.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000085/0001376339-20-000085-index.htm
2020-08-05M KATHLEEN BEHRENSDirectorBuy38,135.0038,135.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000086/0001376339-20-000086-index.htm
2020-08-05Todd NewtonDirectorBuy38,135.0038,135.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000090/0001376339-20-000090-index.htm
2020-10-02WILLIAM A HAWKINSDirectorBuy26,236.006.67174,994.1239,654.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000126/0001376339-20-000126-index.htm
2019-12-16Peter M CarlsonEVP, FinanceBuy49,295.007.10349,994.5049,295.00https://www.sec.gov/Archives/edgar/data/1376339/000137932019000006/0001379320-19-000006-index.htm
2020-08-05William Lawrence PhelanChief Accounting OfficerBuy59,322.0059,322.00https://www.sec.gov/Archives/edgar/data/1376339/000181181420000002/0001811814-20-000002-index.htm
2020-10-02JAMES L BIERMANDirectorBuy26,236.006.67174,994.1264,371.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000124/0001376339-20-000124-index.htm
2020-10-02M KATHLEEN BEHRENSDirectorBuy26,236.006.67174,994.1264,371.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000123/0001376339-20-000123-index.htm
2020-10-02Todd NewtonDirectorBuy26,236.006.67174,994.1264,371.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000128/0001376339-20-000128-index.htm
2020-11-04William Lawrence PhelanChief Accounting OfficerBuy8,474.007.2361,267.0267,796.00https://www.sec.gov/Archives/edgar/data/1376339/000181181420000004/0001811814-20-000004-index.htm
2020-08-05Mark GravesSVP & Chief Compliance OfficerBuy35,254.0079,989.00https://www.sec.gov/Archives/edgar/data/1376339/000180389320000004/0001803893-20-000004-index.htm
2020-08-10Robert Benjamin SteinEVP, Research and DevelopmentBuy81,833.006.11499,999.6381,833.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000095/0001376339-20-000095-index.htm
2020-07-06Peter M CarlsonChief Financial OfficerBuy35,211.005.40190,139.4084,506.00https://www.sec.gov/Archives/edgar/data/1376339/000137932020000002/0001379320-20-000002-index.htm
2020-08-05Charles Robert EvansDirectorBuy29,661.0095,121.00https://www.sec.gov/Archives/edgar/data/1376339/000137633920000087/0001376339-20-000087-index.htm